English
中文
CAS:537-42-8
Storage:Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity:HPLC≥98%
Appearance:White to off-white Solid
Manual Download
Examples of using this product（for reference only）
In Vivo:
Mice（ 10,~40 mg/kg Pte;I.P）:
All mice are randomly divided into six groups as the following: (1) control group; (2) LPS/D-Gal group (LPS 50μg/kg and D-Gal 500 mg/kg); (3–5) LPS/D-Gal + Pte (10,20, and 40 mg/kg) groups; and (6) Pte (40 mg/kg) only group. Prior to the LPS/D-Gal challenge, Pte (10, 20, and 40 mg/kg) is injected intraperitoneally twice in groups 3 to 6 (12 h apart). One hour after the last pretreatment of Pte, mice in 2–5 groups are treated intraperitoneally with LPS (50 μg/kg) and D-Gal (500 mg/kg) to establish ALI models. All animals are sacrificed 9 h after LPS/D-Gal treatment to obtain blood samples and liver tissues.
Reference：
Liu Z, Wang J, Zhang Y, Wu D, Li S, Jiang A, Du C, Xie G. Pterostilbene Exerts Hepatoprotective Effects through Ameliorating LPS/D-Gal-Induced Acute Liver Injury in Mice. Inflammation. 2021 Apr;44(2):526-535. doi: 10.1007/s10753-020-01349-z. Epub 2020 Oct 2. PMID: 33006074.
